Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery
On June 10, 2026, a pharmaceutical company based in Tokyo, Japan called Nxera Pharma Co., Ltd. revealed its partnership with OpenFold, a non-profit AI research consortium dedicated to advancing open-source AI software tools for biology and drug discovery. This collaboration with prominent tech giants like Amazon Web Services, Microsoft, and NVIDIA enhances OpenFold's global reach, attracting various industry leaders such as Bristol Myers Squibb, Novo Nordisk, Bayer, and Roche. This move signifies a significant step towards fostering innovation in the pharmaceutical and biotechnology sectors through collaborative efforts within the international research community.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments